• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Intersect ENT

Medtronic completes Intersect ENT acquisition

May 13, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the Menlo Park, California-based sinus implant maker for $28.25 per share in an all-cash transaction. As a result of the transaction, Medtronic acquires Intersect […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Mergers & Acquisitions, News Well, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Intersect ENT, Medtronic

Medtronic must sell Intersect ENT subsidiary to satisfy FTC concerns

May 12, 2022 By Chris Newmarker

The Federal Trade Commission has issued a proposed order to require Medtronic (NYSE:MDT) to sell a subsidiary of Intersect ENT within 10 days of completing its $1.1 billion acquisition of Intersect ENT. The commission announced May 10 that it voted 4-0 to issue its complaint and accept the proposed consent order for public comment. Under […]

Filed Under: Business/Financial News, Featured, Legal News, Mergers & Acquisitions, News Well Tagged With: antitrust, Federal Trade Commission (FTC), Hemostasis, Intersect ENT, Medtronic

Intersect ENT CEO joins Orthofix board

December 14, 2021 By Sean Whooley

Orthofix (NSDQ:OFIX) announced today that Intersect ENT (NSDQ:XENT) executive Thomas A. West has joined its board of directors. Lewisville, Texas-based Orthofix named West to its board and appointed him to its Compensation and Talent Development Committee. West currently serves as President, CEO & Director of Intersect ENT, which develops drug-delivery devices for ear, nose and […]

Filed Under: Business/Financial News, Featured, Orthopedics Tagged With: Intersect ENT, Orthofix, Personnel Moves

MedTech 100 roundup: Industry ticks up again

August 9, 2021 By Sean Whooley

The medtech industry has been rising for weeks and the latest seven-day stretch was no exception as stocks ticked up again. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 6) at 119.41 points, marking a 0.5% rise from the previous week’s tally of 118.86 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Abiomed, Asensus Surgical, BD, Insulet, Intersect ENT, iRhythm Technologies Inc., Medtronic, Moderna, Philips, ResMed, Vaxart

Medtronic to acquire Intersect ENT in $1.1B deal

August 6, 2021 By Danielle Kirsh

Medtronic (NYSE:MDT) today announced that it has entered a definitive agreement to acquire Intersect ENT (NSDQ:XENT) for $1.1 billion. Medtronic will acquire all outstanding shares of the Menlo Park, Calif.-based sinus implant maker for $28.25 per share in an all-cash transaction. The deal is expected to close toward the end of Medtronic’s 2021–22 fiscal year, subject to […]

Filed Under: Featured, Implants, Mergers & Acquisitions, Wall Street Beat Tagged With: Intersect ENT, Medtronic

Intersect ENT launches VenSure balloon sinus dilation system in U.S.

July 26, 2021 By Danielle Kirsh

Intersect ENT (NSDQ:XENT) today announced that it has commercially launched its VenSure balloon sinus dilation system and Cube 4D navigation system in the U.S. Menlo Park, Calif.-based Intersect ENT designed the VenSure balloon and Cube 4D navigation system to be used in procedures that improve debilitating chronic rhinosinusitis (CRS) symptoms. Cube 4D has VirtuEye photo registration […]

Filed Under: Imaging, Implants Tagged With: Intersect ENT

Intersect ENT wins CE mark for Propel Contour sinus implant

May 20, 2021 By Sean Whooley

Intersect ENT (NSDQ:XENT) announced today that it received CE mark approval for its Propel Contour sinus implant. Menlo Park, Calif.-based Intersect ENT designed its Propel Contour sinus implant to maintain patency and reduce inflammation while conforming to the sinus ostia (openings) through mechanical support and steroid delivery where needed to optimize sinus surgery outcomes. Propel […]

Filed Under: Drug-Device Combinations, Featured, Implants, Otolaryngology/Ear, Nose & Throat (ENT), Regulatory/Compliance Tagged With: CE Mark, Intersect ENT

Intersect ENT appoints VP of sales

May 4, 2021 By Danielle Kirsh

Intersect ENT (NSDQ:XENT) today said it has appointed Mark Alley as VP of sales, effective May 10. Alley most recently served as chief commercial officer at Levita Magnetics. He has more than 20 years of commercial and sales experience and has held numerous leadership roles at Stryker ENT, Spirox and Acclarent. “Mark has a reputation for […]

Filed Under: Business/Financial News, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Intersect ENT

Intersect ENT posts mixed bag Q4

March 9, 2021 By Sean Whooley

Intersect ENT (NSDQ:XENT) posted a mixed bag of results for the fourth quarter, topping consensus revenue estimates but missing on earnings. The Menlo Park, Calif.-based company posted losses of –$20.2 million, or –62¢ per share, on sales of $28.2 million for the three months ended Dec. 31, 2020, for a massive bottom-line slide from losses of […]

Filed Under: Business/Financial News, Drug-Device Combinations, MassDevice Earnings Roundup, Otolaryngology/Ear, Nose & Throat (ENT), Pharmaceutical, Wall Street Beat Tagged With: Intersect ENT

CMS consolidates coverage for Intersect ENT’s corticosteroid-eluting implant

March 8, 2021 By Sean Whooley

Intersect ENT (NSDQ:XENT) announced today that it received consolidated Medicare coverage for its Sinuva sinus implant. Menlo Park, Calif.-based Intersect ENT said in a news release that CMS published an average selling price (ASP) for the Sinuva implant, providing predictability, transparency and confidence of reimbursement for providers and payers in the future. Get the full story […]

Filed Under: Business/Financial News, Drug-Device Combinations, Implants, Medicare, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Intersect ENT

Intersect ENT launches Mini sinus implant

February 11, 2021 By Danielle Kirsh

Intersect ENT today announced that it has launched its Straight Delivery System with its Propel Mini Sinus Implant. The combination packaging originally received FDA premarket approval in July 2020. The Straight Delivery System (SDS) is an extension of Intersect ENT’s Propel family of implants that is engineered for precise, consistent and easy delivery of the […]

Filed Under: Implants, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Intersect ENT

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS